Weiguo Ye insider trades: Gyre Therapeutics (GYRE) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Weiguo reports to the SEC
Open-market buys and sales
7 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 18, 2026 | GYRE | ↓ Sell | 11,000 | $6.25 | $69K | Direct | Jun 22, 2026 (4d) |
| Jun 11, 2026 | GYRE | ↓ Sell | 2,800 | $6.17 | $17K | Direct | Jun 15, 2026 (4d) |
| Jun 10, 2026 | GYRE | ↓ Sell | 20,918 | $6.16 | $129K | Direct | Jun 11, 2026 (1d) |
| Jun 5, 2026 | GYRE | ↓ Sell | 34,976 | $6.25 | $219K | Direct | Jun 8, 2026 (3d) |
| May 26, 2026 | GYRE | ↓ Sell | 7,500 | $6.09 | $46K | Direct | May 27, 2026 (1d) |
| May 21, 2026 | GYRE | ↓ Sell | 22,220 | $6.15 | $137K | Direct | May 22, 2026 (1d) |
| May 19, 2026 | GYRE | ↓ Sell | 9,320 | $6.38 | $59K | Direct | May 20, 2026 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other GYRE insiders
Open-market trades in the last 12 months
About Weiguo Ye's insider trades
Weiguo Ye is Chief Operating Officer at Gyre Therapeutics (GYRE). Since May 19, 2026, Weiguo has reported no open-market purchases and 7 sales worth $675K on SEC Form 4. In the last 12 months: 7 sales ($675K).
Their filings also include option exercises (9 filings), grants and awards (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every GYRE insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.